These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 76588)

  • 1. Hyperviscosity syndrome attributable to hyperglobulinemia in chronic active hepatitis.
    Lee WM; Lebwohl O; Chien S
    Gastroenterology; 1978 May; 74(5 Pt 1):918-21. PubMed ID: 76588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of chronic hepatitis. Correlation of clinical, biochemical and histological parameters in 32 cases.
    Gayotto LC; Strauss E; Alves VA; da Silva LC
    Rev Inst Med Trop Sao Paulo; 1983; 25(6):288-93. PubMed ID: 6200913
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of chronic hepatitis by immunodepressors].
    Magyar I; Kovacs A
    Rev Int Hepatol; 1969; 19(2):147-62. PubMed ID: 4102237
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperviscosity syndrome in plasma cell dyscrasias.
    Mehta J; Singhal S
    Semin Thromb Hemost; 2003 Oct; 29(5):467-71. PubMed ID: 14631546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contribution of liver biopsy and serology of hepatitis C virus to the diagnosis of a moderate and prolonged elevation of aminotransferases].
    Dao T; Lecointe I; Galateau F; Freymuth F; Rideau A; Verwaerde JC; Valla A
    Gastroenterol Clin Biol; 1993; 17(1):37-43. PubMed ID: 8467969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum immunoglobulins in patients with chronic hepatitis C: a surrogate marker of disease severity and treatment outcome.
    Maruyama S; Hirayama C; Horie Y; Yorozu K; Maeda K; Inoue M; Fujii Y; Umeki K; Koda M
    Hepatogastroenterology; 2007 Mar; 54(74):493-8. PubMed ID: 17523306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined form of chronic aggressive hepatitis primary biliary cirrhosis].
    Zimmermann K; Cueni B; Schmid M
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1749-52. PubMed ID: 929135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of aminotransferases to liver histological status in chronic hepatitis C.
    Haber MM; West AB; Haber AD; Reuben A
    Am J Gastroenterol; 1995 Aug; 90(8):1250-7. PubMed ID: 7639225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of puncture biopsy of the liver during diagnostic and follow-up examinations (clinical aspects, immunological markers, images) in chronic hepatitis].
    Gonvers JJ
    Schweiz Med Wochenschr; 1986 Aug; 116(31-32):1030-5. PubMed ID: 2428101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse.
    Montano-Loza AJ; Carpenter HA; Czaja AJ
    Am J Gastroenterol; 2007 May; 102(5):1005-12. PubMed ID: 17319926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological features of hepatitis C virus infection in patients with chronic renal failure and renal transplantation.
    Demirhan B; Boyacioğlu S; Kart H; Telatar H
    Transplant Proc; 1996 Aug; 28(4):2328-30. PubMed ID: 8769239
    [No Abstract]   [Full Text] [Related]  

  • 12. Oligoclonal immunoglobulin bands in serum in association with chronic viral hepatitis.
    Tsianos EV; Di Bisceglie AM; Papadopoulos NM; Costello R; Hoofnagle JH
    Am J Gastroenterol; 1990 Aug; 85(8):1005-8. PubMed ID: 2375310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory assessment of severe chronic active liver disease during and after corticosteroid therapy: correlation of serum transaminase and gamma globulin levels with histologic features.
    Czaja AJ; Wolf AM; Baggenstoss AH
    Gastroenterology; 1981 Apr; 80(4):687-92. PubMed ID: 6162704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gammopathy in liver disease.
    Eliakim M; Zlotnick A; Slavin S
    Prog Liver Dis; 1972; 4():403-17. PubMed ID: 4126131
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic septal hepatitis.
    Gerber MA; Vernace S
    Virchows Arch A Pathol Anat Histol; 1974; 363(4):303-9. PubMed ID: 4138635
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunofluorescent investigations on liver biopsy specimens with FITC-labeled protein from organs].
    Meyer zum Büschenfelde ; Kössling FK; Dietz R
    Verh Dtsch Ges Pathol; 1969; 53():325-30. PubMed ID: 4190740
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis.
    Chrétien P; Chousterman M; Abd Alsamad I; Ozenne V; Rosa I; Barrault C; Lons T; Hagège H
    J Autoimmun; 2009; 32(3-4):201-5. PubMed ID: 19324518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Humoral and histological correlations in chronic aggressive hepatitis without necrotic bridges].
    Sansonno DE; Giustino V; Buongiorno GP; Ardito D; Demundo T; Loiodice L
    Minerva Med; 1980 Oct; 71(42):3063-6. PubMed ID: 6167906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fine structural studies in active chronic hepatitis with special reference to the mesenchyma].
    Gerlach U; Manitz G; Themann H
    Acta Hepatosplenol; 1969; 16(2):90-105. PubMed ID: 4893999
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of chronic infantile hepatitis with D-penicillamine (author's transl)].
    Weingärtner L; Metzke H; Rath FW; Baum WF; Preiss U; Heinrichs I
    Klin Padiatr; 1977 May; 189(3):211-9. PubMed ID: 559874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.